---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-007063"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T09:28:31.887737+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Galectin Therapeutics updates corporate presentation; no specific data in filing excerpt

## Summary
- Filing indicates updated corporate presentation posted on website March 5, 2025.
- Presentation intended for use at conferences and investor meetings.
- Exhibit content (slides) not included in provided text, limiting extractable news.
- No new financial guidance, clinical milestones, or operational changes disclosed.

## SEC filing metadata
- accession: 0001140361-25-007063
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/0001140361-25-007063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/ef20044880_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-007063
- JSON: https://secwatch.observer/filing/0001140361-25-007063.json
- Plain text: https://secwatch.observer/filing/0001140361-25-007063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.